Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Yuriy Kaloshnikov

Bookmark and Share
Kapusta Research Initiates Sell Rating on ATRN with a Target Price of .023
Kapusta Research Initiates Sell Rating on ATRN with a Target Price of .023

BriefingWire.com, 2/13/2012 - After careful consideration, Kapusta Research has initiated a Caveat Emptor sell rating on ATRN (ATRINSIC, INC), with a target price of .023

The target price is almost 90% off current levels, our last research reports included AMWI, NSRS - both stocks lost over 60% the day after our report.

We will continue to stand by our sell rating on ATRN (ATRINSIC, INC) and target price of .023, and continue coverage until it falls to these levels.

Kapusta Research Holds No Position in ATRN long or short, and has initiated this research months after our buy alert at .01 - which represents over 2000% gains.

PLEASE READ DISCLAIMER BELOW ALSO VIEW: http://www.kapustaresearchgroup.com/#!disclaimer

WE ARE NOT REGISTERED BROKER DEALERS OR REGISTERED INVESTMENT ADVISORS, AND ARE NOT QUALIFIED TO GIVE FINANCIAL ADVICE

RESEARCH REPORTS: RESEARCH REPORTS ARE PREPARED FOR INFORMATIONAL PURPOSES ONLY. The report/research reports by Kapusta Research Group do not take into account the investment objectives, financial situation, or particular needs of any particular person. The report/research reports do not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Kapusta Research Group, nor its parent, is registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission or with any state securities regulatory authority. ALL INFORMATION IN ANY REPORTS CONDUCTED BY KAPUSTA RESEARCH GROUP REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, KAPUSTA RESEARCH GROUP WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, KAPUSTA RESEARCH GROUP WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO ANY PRESENTATION OF INFORMATION ON THIS SITE OR CONDUCTED RESEARCH REPORTS.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2026 Proserve Technology, Inc.